You are currently viewing a new version of our website. To view the old version click .

Editorial Board Members’ Collection Series: Inflammatory Bowel Disease

Special Issue Information

Dear Colleagues,

Inflammatory Bowel Disease: looking to new horizons

Inflammatory bowel diseases (IBD) are characterised by active chronic inflammation in the gastrointestinal tract with huge morbidity for patients and large healthcare costs. IBD can be classified as Crohn’s disease (CD), ulcerative colitis (UC), or IBD unclassified (IBDU). Now seen as a global condition, prevalence of this incurable condition continues to increase. Whilst much is known about IBD, there remain many gaps in our understanding of the pathogenesis of IBD, variable approaches to the management of IBD, and inconsistent outcomes. This Collection Series aims to draw together articles focusing on current aspects of IBD and key aspects looming on the horizon. These might include therapeutic agents, such as the use of small molecules (JAK kinase inhibitors and S1P receptor modulators), and therapeutic approaches, such as treat-to-target or combination trials. Additional articles could focus on aspects of the pathogenesis of IBD (with regard to environmental factors, host immune responses, or the intestinal microbiome) and outcomes.

Prof. Dr. Laurent Peyrin-biroulet
Prof. Dr. Andrew Day
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • inflammatory bowel diseases
  • Crohn’s disease
  • ulcerative colitis
  • JAK kinase inhibitors
  • SIP receptor modulators
  • therapeutic approaches

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383Creative Common CC BY license